Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):295–298. doi: 10.1111/j.1476-5381.1996.tb15402.x

The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider.

R T Palframan 1, S K Costa 1, P Wilsoncroft 1, E Antunes 1, G de Nucci 1, S D Brain 1
PMCID: PMC1909644  PMID: 8735630

Abstract

1. The possibility that tachykinin NK1 receptors are involved in the plasma extravasation evoked by intradermal (i.d.) injection of Phoneutria nigriventer venom (PNV) in rat dorsal skin in vivo has been investigated. 2. Local oedema formation induced by the i.d. injection of test agents was measured by the extravascular accumulation of intravenously (i.v.) injected 125I-labelled human serum albumin over a 30 min period. 3. The tachykinin NK1 agonist, GR73632 (30 pmol per site), induced local oedema formation which was potentiated by co-injection with the neuropeptide vasodilator, calcitonin gene-related peptide (CGRP, 10 pmol per site). The non-peptide tachykinin NK1 receptor antagonist, SR140333 (0.03-1 nmol per site co-injected, i.d.) significantly inhibited (0.3 nmol per site, P < 0.05; 1 nmol per site, P < 0.001) local oedema formation induced by GR73632 with CGRP but not that induced by histamine (10 nmol per site) with CGRP. 4. PNV (0.03-0.3 microgram per site) injected i.d. induced dose-dependent local oedema formation. SR140333 (1 nmol per site, co-injected i.d.) inhibited oedema formation; with complete inhibition observed at doses of 0.03 microgram (P < 0.05) and 0.1 microgram (P < 0.001); and partial inhibition (50%) observed with the highest dose of PNV, 0.3 microgram (P < 0.05). 5. Local oedema formation induced by PNV was not affected by systemic pretreatment with the bradykinin B2 receptor antagonist, Hoe 140 (80 nmol kg-1, i.v.), which was used at a dose which significantly inhibited oedema formation by bradykinin (1 nmol per site). 6. Local oedema formation induced by PNV was significantly inhibited (P < 0.01) by co-injection of the histamine H1 receptor antagonist, mepyramine (2.5 nmol per site), together with the 5-hydroxytryptamine (5-HT) antagonist, methysergide (2.8 nmol per site). 7. In the presence of all three antagonists (mepyramine 2.5 nmol per site; methysergide, 2.8 nmol per site and SR140333 1 nmol per site), the plasma extravasation induced by PNV was further significantly inhibited (P < 0.001, when compared with PNV injected i.d. alone; P < 0.05 when compared with PNV co-injected with mepyramine and methysergide and P < 0.01, when compared with PNV co-injected with SR140333). 8. These results suggest that oedema formation evoked by i.d. PNV in rat skin may be partially mediated via a mechanism involving tachykinin NK1 receptors and that this effect is independent of histamine and 5-HT.

Full text

PDF
295

Images in this article

296Figure 1
on p.296
296Figure 2
on p.296
297Figure 4
on p.297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antunes E., Marangoni R. A., Brain S. D., de Nucci G. Phoneutria nigriventer (armed spider) venom induces increased vascular permeability in rat and rabbit skin in vivo. Toxicon. 1992 Sep;30(9):1011–1016. doi: 10.1016/0041-0101(92)90045-7. [DOI] [PubMed] [Google Scholar]
  2. Brain S. D., Williams T. J. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 1985 Dec;86(4):855–860. doi: 10.1111/j.1476-5381.1985.tb11107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brain S. D., Williams T. J. Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol. 1989 May;97(1):77–82. doi: 10.1111/j.1476-5381.1989.tb11926.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Emonds-Alt X., Doutremepuich J. D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J. P., Proietto V. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol. 1993 Dec 21;250(3):403–413. doi: 10.1016/0014-2999(93)90027-f. [DOI] [PubMed] [Google Scholar]
  5. Escott K. J., Brain S. D. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br J Pharmacol. 1993 Oct;110(2):772–776. doi: 10.1111/j.1476-5381.1993.tb13878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lucas S. Spiders in Brazil. Toxicon. 1988;26(9):759–772. doi: 10.1016/0041-0101(88)90317-0. [DOI] [PubMed] [Google Scholar]
  7. Marangoni R. A., Antunes E., Brain S. D., de Nucci G. Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo. Br J Pharmacol. 1993 Jun;109(2):539–543. doi: 10.1111/j.1476-5381.1993.tb13604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marangoni R. A., Antunes E., Brain S. D., de Nucci G. Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo. Br J Pharmacol. 1993 Jun;109(2):539–543. doi: 10.1111/j.1476-5381.1993.tb13604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rezende Júnior L., Cordeiro M. N., Oliveira E. B., Diniz C. R. Isolation of neurotoxic peptides from the venom of the 'armed' spider Phoneutria nigriventer. Toxicon. 1991;29(10):1225–1233. doi: 10.1016/0041-0101(91)90195-w. [DOI] [PubMed] [Google Scholar]
  10. Walker K., Perkins M., Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1995 Jan;26(1):1–26. doi: 10.1016/0197-0186(94)00114-a. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES